Spectrum Pharmaceuticals is a biotechnology company primarily focused on oncology and hematology. Spectrum has fully integrated commercial and drug development operations and currently markets two oncology drugs: FUSILEV for Injection and ZEVALIN Injection for intravenous use. The company also has two drugs in late stage development. Spectrum’s strategy is to acquire, develop, and commercialize a large and diverse pipeline of late-stage clinical and commercial drug products. For more information, visit the company’s Web site at www.sppirx.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: